DZ2503A1 - Formulation pure injectable d'un composé anesthésique. - Google Patents

Formulation pure injectable d'un composé anesthésique.

Info

Publication number
DZ2503A1
DZ2503A1 DZ980113A DZ980113A DZ2503A1 DZ 2503 A1 DZ2503 A1 DZ 2503A1 DZ 980113 A DZ980113 A DZ 980113A DZ 980113 A DZ980113 A DZ 980113A DZ 2503 A1 DZ2503 A1 DZ 2503A1
Authority
DZ
Algeria
Prior art keywords
anesthetic compound
pure formulation
injectable
injectable pure
formulation
Prior art date
Application number
DZ980113A
Other languages
English (en)
French (fr)
Inventor
Vicenzo De Tommaso
Original Assignee
Saucy Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Saucy Ltd filed Critical Saucy Ltd
Application granted granted Critical
Publication of DZ2503A1 publication Critical patent/DZ2503A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Anesthesiology (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DZ980113A 1997-05-26 1998-05-25 Formulation pure injectable d'un composé anesthésique. DZ2503A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH01224/97A CH692322A5 (it) 1997-05-26 1997-05-26 Formulazione iniettabile limpida di Propofol.

Publications (1)

Publication Number Publication Date
DZ2503A1 true DZ2503A1 (fr) 2005-01-25

Family

ID=4205400

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ980113A DZ2503A1 (fr) 1997-05-26 1998-05-25 Formulation pure injectable d'un composé anesthésique.

Country Status (23)

Country Link
US (1) US6326406B1 (h)
EP (1) EP0991405B1 (h)
JP (1) JP2001527577A (h)
KR (1) KR20010013011A (h)
CN (1) CN1268051A (h)
AR (1) AR012853A1 (h)
AT (1) ATE230984T1 (h)
AU (1) AU735020B2 (h)
BR (1) BR9809492A (h)
CA (1) CA2291261A1 (h)
CH (1) CH692322A5 (h)
DE (1) DE69810771D1 (h)
DZ (1) DZ2503A1 (h)
HU (1) HUP0002117A3 (h)
IN (1) IN187550B (h)
MY (1) MY132911A (h)
NO (1) NO995831L (h)
PA (1) PA8451701A1 (h)
PE (1) PE75299A1 (h)
PL (1) PL337026A1 (h)
TR (1) TR200000116T2 (h)
WO (1) WO1998053805A1 (h)
ZA (1) ZA984314B (h)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6749868B1 (en) 1993-02-22 2004-06-15 American Bioscience, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
JP4198318B2 (ja) 1998-08-19 2008-12-17 ヤーゴテック アクチェンゲゼルシャフト プロポフォールの注射可能水性分散物
WO2000044369A1 (en) * 1999-01-28 2000-08-03 Dinesh Shantilal Patel Parenteral solution of propofol (2,6-diisoprophylphenol) and 2.5- di- 0- methyl- 1.4;3.6- dianhydro- d- glucitol as a solvent
US6177477B1 (en) * 1999-03-24 2001-01-23 American Home Products Corporation Propofol formulation containing TRIS
US6635456B2 (en) * 2001-02-09 2003-10-21 Fidia Farmaceutici S.P.A. Procedure for the preparation of pure phosphatides with phospholipase D
US6803046B2 (en) * 2002-08-16 2004-10-12 Bracco International B.V. Sincalide formulations
KR100482269B1 (ko) * 2002-10-08 2005-04-14 센츄론(주) 2,6-디이소프로필페놀을 활성성분으로 하는 수용액상의마취용 주사제 및 그 제조방법
KR20200083657A (ko) * 2002-12-09 2020-07-08 아브락시스 바이오사이언스, 엘엘씨 약리학적 물질의 조성물 및 그 전달방법
US20040225022A1 (en) * 2003-05-09 2004-11-11 Desai Neil P. Propofol formulation containing reduced oil and surfactants
US8476010B2 (en) 2003-07-10 2013-07-02 App Pharmaceuticals Llc Propofol formulations with non-reactive container closures
US8546453B2 (en) 2003-08-14 2013-10-01 Rensheng Zhang Propofol compositions and methods for reducing pain associated with propofol injection
JP2005154305A (ja) * 2003-11-21 2005-06-16 Showa Yakuhin Kako Kk ヒアルロン酸含有組成物の製造方法
CN100358513C (zh) * 2005-04-07 2008-01-02 常州市第四制药厂有限公司 一种丙泊酚注射液的制备工艺
AU2006284657B2 (en) 2005-08-31 2012-07-19 Abraxis Bioscience, Llc Compositions and methods for preparation of poorly water soluble drugs with increased stability
ES2784794T3 (es) 2005-08-31 2020-10-01 Abraxis Bioscience Llc Composiciones que comprenden agentes farmacéuticos poco solubles en agua y agentes antimicrobianos
EA201100152A1 (ru) * 2008-11-20 2011-12-30 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. Лекарственные формы производного пиразолона
US11110063B2 (en) 2017-08-25 2021-09-07 MAIA Pharmaceuticals, Inc. Storage stable sincalide formulations
CA3088017A1 (en) * 2018-03-07 2019-09-12 Andrew Xian Chen Aqueous formulations for insoluble drugs
JP7135670B2 (ja) * 2018-09-27 2022-09-13 住友電気工業株式会社 光ファイバ及び紫外線硬化型樹脂組成物
JP7063217B2 (ja) * 2018-09-27 2022-05-09 住友電気工業株式会社 光ファイバの製造方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1089510B (de) 1959-03-23 1960-09-22 Rudolf Reiss Dr Verfahren zur Herstellung waessriger, injizierbarer Loesungen von 2-Methoxy-4-allylphenoxyessigsaeure-N, N-Diaethylamid
GB1472793A (en) * 1974-03-28 1977-05-04 Ici Ltd Pharmaceutical compositions
US4798846A (en) * 1974-03-28 1989-01-17 Imperial Chemical Industries Plc Pharmaceutical compositions
DE3221579A1 (de) 1982-06-08 1983-12-22 Eckert, Theodor, Prof. Dr., 4400 Münster Solubilisierung von in wasser schwerloeslichen wirkstoffen in waessrige loesung unter verwendung eines gemisches von cholinphosphorsaeureglycerindiester (cholin-lecithin) und natriumdesoxycholat als loesungsvermittler und die therapeutische verwendung der so erhaltenen waessrigen loesungen
CA1319886C (en) 1987-02-03 1993-07-06 Alberto Ferro Mixed micelle solutions
US5085864A (en) * 1989-10-30 1992-02-04 Abbott Laboratories Injectable formulation for lipophilic drugs
DE4039602A1 (de) * 1990-12-12 1992-06-17 Bauer Kurt Heinz Prof Dr Pharmazeutische formulierungen
GB9405593D0 (en) 1994-03-22 1994-05-11 Zeneca Ltd Pharmaceutical compositions
ZA962214B (en) 1995-04-10 1996-10-07 Farmarc Nederland Bv Pharmaceutical composition
WO1997010814A1 (en) 1995-09-18 1997-03-27 Vesifact Ag Propofol nanodispersions
US5637625A (en) * 1996-03-19 1997-06-10 Research Triangle Pharmaceuticals Ltd. Propofol microdroplet formulations

Also Published As

Publication number Publication date
CA2291261A1 (en) 1998-12-03
NO995831L (no) 2000-01-26
NO995831D0 (no) 1999-11-26
HUP0002117A3 (en) 2001-04-28
ZA984314B (en) 1998-12-08
CH692322A5 (it) 2002-05-15
PA8451701A1 (es) 2000-05-24
AR012853A1 (es) 2000-11-22
BR9809492A (pt) 2000-06-20
EP0991405A1 (en) 2000-04-12
PE75299A1 (es) 1999-08-26
JP2001527577A (ja) 2001-12-25
IN187550B (h) 2002-05-18
HUP0002117A2 (hu) 2000-12-28
WO1998053805A1 (en) 1998-12-03
PL337026A1 (en) 2000-07-31
AU8209798A (en) 1998-12-30
AU735020B2 (en) 2001-06-28
KR20010013011A (ko) 2001-02-26
US6326406B1 (en) 2001-12-04
ATE230984T1 (de) 2003-02-15
TR200000116T2 (tr) 2000-05-22
CN1268051A (zh) 2000-09-27
MY132911A (en) 2007-10-31
EP0991405B1 (en) 2003-01-15
DE69810771D1 (de) 2003-02-20

Similar Documents

Publication Publication Date Title
DZ2503A1 (fr) Formulation pure injectable d'un composé anesthésique.
ITMI951278A0 (it) Formulazioni di analoghi dell'insulina
DK1124961T3 (da) Trombopoietiske forbindelser
PT1413582E (pt) Pirrolobenzodiazepinas dimericas
FI972292A0 (fi) Administrering av diabetes
DE69514087D1 (de) Pharmazeutisch aktive substituierte aromatische verbindungen
ZA986829B (en) Use of substituted 2,4-imidazolidinedione compounds as analgesics
KR970706248A (ko) 불화된 유기화합물 제조방법(the preparation of fluorinated organic compounds)
IT1307267B1 (it) Procedimento di rafforzamento di attivita' antitumorale di farmacigrezzi, composizione contenente un farmaco grezzo rafforzante
DE59912915D1 (de) Herstellung von 4,4'-Diketo-carotinoiden
EP0605983A3 (en) Isulin analogs.
ID24677A (id) Kombinasi senyawa aktif fungisidal
IT1303793B1 (it) "composizione farmaceutica comprendente un composto organico donatoredi ossido nitrico (no)"
FR2695297B1 (fr) Composition d'agent désinfectant.
DE69825193D1 (de) Pyridazinon-Verbindungen enthaltenden Zusammensetzungen zur oralen Verabreichung
ATE282608T1 (de) Chinoxalindionen
FR2718643B1 (fr) Hépato-dialyseur extra-corporel utilisant le foie prélevé d'un être vivant.
IT1320401B1 (it) Procedimento per la fabbricazione di componenti di un'ossatura ecomponenti di ossatura.
ID23032A (id) Komposisi insektisida
ITRM980538A1 (it) Kit per la somministrazione di quantita' presosate di farmaci per via ionoforetica
ZA989550B (en) Use of inhaled no as anti-inflammatory agent.
ITRM970049A1 (it) Procedimento per la preparazione dell'acido 2-iodossibenzoico.
ITBO960414A0 (it) Apparecchiatura per l'assemblaggio automatico di siringhe
ID19787A (id) Senyawa 25-hidroksi-16-ena-26,27-bishomo-kolekalsiferol
IT1301693B1 (it) Composizioni endovenose di idrossiurea.